Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025958
Disease: Microcephaly
Microcephaly
0.400 Biomarker disease GENOMICS_ENGLAND Mutations in genes encoding condensin complex proteins cause microcephaly through decatenation failure at mitosis. 27737959 2016
CUI: C0025958
Disease: Microcephaly
Microcephaly
0.400 Biomarker disease HPO
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.310 Biomarker disease BEFREE Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma. 31523845 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.310 Biomarker disease CTD_human Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. 28284560 2017
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE
0.300 GeneticVariation disease UNIPROT Mutations in genes encoding condensin complex proteins cause microcephaly through decatenation failure at mitosis. 27737959 2016
CUI: C0026351
Disease: Moderate intellectual disability
Moderate intellectual disability
0.100 Biomarker disease HPO
CUI: C1857679
Disease: Sloping forehead
Sloping forehead
0.100 Biomarker phenotype HPO
CUI: C0008626
Disease: Congenital chromosomal disease
Congenital chromosomal disease
0.010 Biomarker group BEFREE Furthermore, NCAPH-knockdown cells showed an increase in chromosomal aberrations and DNA damage via activation of the DNA damage response (Chk1/Chk2) signaling pathways. 31784646 2019
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.010 AlteredExpression disease BEFREE Our results showed that NCAPH was overexpressed in clinical PC specimens (GEPIA) and cell lines. 31784646 2019
CUI: C0346647
Disease: Malignant neoplasm of pancreas
Malignant neoplasm of pancreas
0.010 AlteredExpression disease BEFREE Our results showed that NCAPH was overexpressed in clinical PC specimens (GEPIA) and cell lines. 31784646 2019
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 Biomarker disease BEFREE Bioinformatics analysis revealed that NCAPH is involved in regulating the PCa cell cycle by interacting with a number of proteins, including non-SMC condensin I complex subunit D2, non-SMC condensin I complex subunit G, structural maintenance of chromosomes 4, structural maintenance of chromosomes 2, Aurora kinase A, Aurora kinase B, cyclin-dependent kinase 1, H2A histone family member Z, POC1 centriolar protein A and histone cluster 2 H2A family member C. In summary, the present results suggest NCAPH may be a novel and beneficial diagnostic and therapeutic target in PCa. 31186803 2019
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 Biomarker disease BEFREE Bioinformatics analysis revealed that NCAPH is involved in regulating the PCa cell cycle by interacting with a number of proteins, including non-SMC condensin I complex subunit D2, non-SMC condensin I complex subunit G, structural maintenance of chromosomes 4, structural maintenance of chromosomes 2, Aurora kinase A, Aurora kinase B, cyclin-dependent kinase 1, H2A histone family member Z, POC1 centriolar protein A and histone cluster 2 H2A family member C. In summary, the present results suggest NCAPH may be a novel and beneficial diagnostic and therapeutic target in PCa. 31186803 2019
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 Biomarker phenotype BEFREE Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma. 31523845 2019
Metastatic castration-resistant prostate cancer
0.010 AlteredExpression disease BEFREE Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p. 30818424 2019
CUI: C0007102
Disease: Malignant tumor of colon
Malignant tumor of colon
0.010 Biomarker disease BEFREE Collectively, these findings reveal an important role of NCAPH in CC, indicating that NCAPH could be used as a new therapeutic target in future. 28300828 2017
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.010 Biomarker disease BEFREE Collectively, these findings reveal an important role of NCAPH in CC, indicating that NCAPH could be used as a new therapeutic target in future. 28300828 2017